Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
- Conditions
- Avian InfluenzaInfluenza Immunisation
- Interventions
- Biological: A/H7N9Drug: MF59Other: Phosphate Buffered Saline (PBS) diluent
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2021-05-17
- Target Recruit Count
- 372
- Registration Number
- NCT03682120
- Locations
- 🇺🇸
Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States
🇺🇸Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington, United States
🇺🇸University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic, Birmingham, Alabama, United States
Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device
- Conditions
- ImmunisationHantavirus Pulmonary Infection
- Interventions
- Biological: Andes virus DNA vaccineOther: Placebo
- First Posted Date
- 2018-09-24
- Last Posted Date
- 2022-11-22
- Target Recruit Count
- 48
- Registration Number
- NCT03682107
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
Development of Childhood Anti-Influenza Immunity
- Conditions
- InfluenzaInfluenza Immunisation
- Interventions
- Biological: Influenza Virus Quadrivalent Inactivated Vaccine
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2022-03-18
- Target Recruit Count
- 125
- Registration Number
- NCT03673345
- Locations
- 🇺🇸
University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States
Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2022-05-03
- Target Recruit Count
- 49
- Registration Number
- NCT03670355
- Locations
- 🇺🇸
Bridge HIV CRS, San Francisco, California, United States
🇺🇸Alabama CRS, Birmingham, Alabama, United States
🇺🇸University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States
Liver Transplantation With Tregs at UCSF
- Conditions
- Liver Transplant
- Interventions
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2024-04-23
- Target Recruit Count
- 42
- Registration Number
- NCT03654040
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Tocilizumab in Cardiac Transplantation
- Conditions
- Heart Transplant
- Interventions
- Biological: PlaceboBiological: tocilizumabDrug: Standard of Care Triple IS
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2024-03-26
- Target Recruit Count
- 385
- Registration Number
- NCT03644667
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania (PAUP), Philadelphia, Pennsylvania, United States
🇺🇸Allegheny General Hospital (PAAG), Pittsburgh, Pennsylvania, United States
🇺🇸Baylor University Medical Center (TXTX), Dallas, Texas, United States
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
- Conditions
- MalariaZikaChikungunyaLeishmaniasisDengue
- Interventions
- Other: Four vector feedingOther: One vector feeding
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2021-12-08
- Target Recruit Count
- 95
- Registration Number
- NCT03641339
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection
- Conditions
- Syphilis
- Interventions
- Drug: Benzathine Penicillin
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2023-12-26
- Target Recruit Count
- 249
- Registration Number
- NCT03637660
- Locations
- 🇺🇸
Fenway Health - The Fenway Institute, Boston, Massachusetts, United States
🇺🇸Magee Women's Hospital of UPMC - Reproductive Infectious Disease Research, Pittsburgh, Pennsylvania, United States
🇺🇸University of Washington - Harborview Medical Center - Center for AIDS and STD, Seattle, Washington, United States
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
- Conditions
- HIV Infections
- Interventions
- Drug: Standard of Care (SOC) Oral ARTDrug: Oral RPVDrug: Oral CABDrug: RPV-LA Loading DoseDrug: CAB-LA Loading DoseDrug: RPV-LA Maintenance DoseDrug: CAB-LA Maintenance Dose
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2024-11-20
- Target Recruit Count
- 310
- Registration Number
- NCT03635788
- Locations
- 🇺🇸
University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States
🇺🇸Northwestern University CRS, Chicago, Illinois, United States
🇺🇸Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS, Boston, Massachusetts, United States
Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Biological: rRSV A/Maryland/001/11
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2024-05-21
- Target Recruit Count
- 40
- Registration Number
- NCT03624790
- Locations
- 🇺🇸
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States